Skip to content

A study on the usefulness of perfusion CT prescribing the amount of contrast agent by body weight in brain tumor

A study on the usefulness of perfusion CT prescribing the amount of contrast agent by body weight in brain tumor - A study on the usefulness of perfusion CT prescribing the amount of contrast agent by body weight in brain tumor

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033531
Enrollment
50
Registered
2018-12-01
Start date
2018-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain tumor

Interventions

None listed

Sponsors

saitama medical center, saitama medical university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Case in which CT perfusion was performed in brain tumor

Exclusion criteria

Exclusion criteria: We will publish this research in opt-out and exclude cases that we could not obtain consent.

Design outcomes

Primary

MeasureTime frame
This study is a retrospective study. In past clinical cases, we narrow down the case of CT perfusion and standard MR perfusion, compare both, and evaluate the usefulness.

Countries

Japan

Contacts

Public ContactJun Nakane

saitama medical center, saitama medical university radiology service

jun_n@saitama-med.ac.jp049-228-3518

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026